Home Overview Press Room Blog Publications For Students about us
Search

About Biopolitics, Parties, Pundits & Human Biotechnology


Policy decisions about human biotechnologies have typically been debated among elite commissions and experts. But controversy is increasingly spilling over into mainstream news media and political debates.

This trend has been most notable in the United States, with the emergence of human embryonic stem cell research as a political issue. Stem cell debates at the policy level have made this discussion far more visible to the public.

The Bush Administration's restrictions on federal funding for human embryonic stem cell research elevated the issue to the front pages of newspapers. Shortly after its announcement in 2001, partisan battle lines were drawn in ways that mirror the abortion rights divide.

Republicans hoped that opposition to research that destroys embryos would increase support among their party's religious conservative base. Democrats countered by assembling a coalition of patient advocates, biomedical researchers, and biotechnology entrepreneurs and appealed to moderate swing voters and Republicans who they believed would be swayed by promises of cures.

There were some notable exceptions to this partisan line-up. Some conservatives support embryonic stem cell research; some liberals and progressives who support the research in principle criticize aspects of its conduct and regulation. Unfortunately, the polarized debate has frequently distorted facts while obscuring a range of important social issues unrelated to the moral status of embryos.



California needs to do more than apologize to people it sterilizedby The Times editorial boardLos Angeles Times January 21st, 2017State officials should quickly begin tracking down these elderly victims who were abused decades ago while under the stateís care. Time is short to do right by them.
Written evidence for the Genomics and Genome-Editing Inquiry of the House of Commons Science and Technology Committee[cites CGS]by Edward Hockings and Lewis CoyneEthics and GeneticsJanuary 20th, 2017UKís bioscience policy has been framed in terms of commercial value at the expense of substantive public consultation and broader deliberation.
When a Study Cast Doubt on a Heart Pill, the Drug Company Turned to Tom Priceby Robert FaturechiProPublicaJanuary 19th, 2017After hearing from a company whose CEO was a campaign contributor, a congressional aide to Donald Trumpís HHS nominee repeatedly pushed a federal health agency to remove a critical drug study from its website.
California voters were promised cures. But the state stem cell agency has funded just a trickle of clinical trials[cites CGS's Marcy Darnovsky]by Charles PillerSTATJanuary 19th, 2017The Institute of Medicine said in a 2013 review that institutionalized conflicts of interest have raised questions about "the integrity and independence of some of CIRMís decisions."
Do We Need an International Body to Regulate Genetic Engineering?by Kristen V. BrownGizmodoJanuary 18th, 2017Science reaches across borders, which poses challenging questions for us to decide what the future should look like--locally and globally.
Controversial IVF technique produces a baby girl -- and for some, that's a problemby Susan ScuttiCNNJanuary 18th, 2017Stakes are rising as genetic modifications produced in a girl baby could be passed onto her future children. The risks remain unknown.
CGS Board Member Leads Redress Call for California Survivors of Eugenic Sterilization by Marcy DarnovskyJanuary 16th, 2017Scholars estimate that more than 800 people alive today were sterilized in California state institutions, and call on the state to consider compensation and redress.
Fertility Futility: Procedures Claimed to Boost IVF Success Lack Supporting Evidenceby Sandy OngNewsweekJanuary 12th, 2017Of nearly 30 expensive clinic add-ons reviewed by researchers, only one drew some evidence of boosting the chances of having a baby.
The Promise and Peril of Emerging Reproductive Technologiesby Ekaterina PeshevaHarvard Medical SchoolJanuary 11th, 2017IVG, thus far successful only in mice, allows scientists to create embryos in a lab by reprogramming any type of adult cell to become a sperm or egg cell.
Obama vs. Trump: 5 ways they clash ó or donít ó on health and scienceby Dylan ScottSTATJanuary 9th, 2017While Trump might play some wild cards in medicine, science, and public health, there may be some surprising continuity with President Obamaís administration.
Displaying 1-10 of 1562  
Next >> 
Last Page » 
« Show Complete List » 


ESPAÑOL | PORTUGUÊS | Русский

home | overview | blog | publications| about us | donate | newsletter | press room | privacy policy

CGS • 1122 University Ave, Suite 100, Berkeley, CA 94702 • • (p) 1.510.665.7760 • (F) 1.510.665.8760